Emmanuel Raffoux

10PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical molecular engineering of nucleic acids and proteinsLiquid biopsiesMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 11, 2026
Real-world patterns of treatment intensity and prognostic model performance in older acute myeloid leukemia: insights from the French ALFA-PPP Cohort.

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|May 28, 2026
Ultra-high-sensitivity next-generation sequencing-based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort.

|May 12, 2026
Comprehensive mutational profiling and clinical outcome of adult acute myeloid leukemia patients with NUP98 rearrangement.

|Mar 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemia.

Loïc Vasseur, Matthieu Duchmann, Nicolas Duployez

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

Pageof 2

Frequent Collaborators

6 joint publications

Raphaël Itzykson

5 joint publications

Nicolas Duployez

5 joint publications

Lionel Adès

4 joint publications

Delphine Lebon